{"name":"Tempest Therapeutics","slug":"tempest-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":295000,"revenueGrowth":-54.8,"grossMargin":0,"rdSpend":18337000,"netIncome":-41843000,"cash":41488000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPTldBSUFuSmJLTW4wbHFXOGlIS2NTUW5yVGgtd25JajFaamt1Z2VhS1ZURUcyMnl3MXRMakYtS3RrVDdRTzdCZDluX0JxdGNscjZyZE1JejZDeGs2dHk5VWN1bmJTdVNhdy1pR2d1SDVuOE14WjFldE5LSThIQkZDb18wcmFuM09wOG1zN3k0eTIyTGxULTBlVy1PeXlpVDNMcDhjV3Z3UzdkRC1hQm5OWkt6cDR3YVAwVExtZHcxZVdnN3JqX3ZJNFltbXdSajNpZGc?oc=5","date":"2026-03-23","type":"pipeline","source":"GlobeNewswire","summary":"Tempest Therapeutics Announces Up To $6 Million Private Placement - GlobeNewswire","headline":"Tempest Therapeutics Announces Up To $6 Million Private Placement","sentiment":"neutral"},{"date":"2026-03-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOYzFoaG1UQzRjdnY4UUM4RVhMN2RDc1RlU2VYUFRFVWlYbC16ZTFaUnE3dnVzY2xNVmYzWHRUTUFNQkFMcnlBTy1TSFBnQ05BNVM0d3BGWHRaTEhJZjBKWS1GVjZBbmgwZ3dfNU9ubDlLOHowVjVCZl9DNXFXUThKTmpfQlBMVEFCMkdFdGZsZi1obVdDU2xDNlBzbnpKcGFNbHVjMHdXa1RfNVJoa2p5bWxFOEpjWHNEVzZxbFpNb19id1E5X2dRbGl5OFZxY1pKMU9Zcm9OWEdYbmRSdTVVdTVBWHRwT05FeFllNjZjNk5LUQ?oc=5","date":"2026-02-11","type":"deal","source":"GlobeNewswire","summary":"Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets - GlobeNewswire","headline":"Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQbzhmd2pxU05iYzlxMjkxdlhkRkp3dzU3RVlZQnhhSkJiVDVNUF91N2pRSjVyMUlDUmVDVEZfQ3NXUGJKa2NmYTRlcm9oLXFXVXdHYmVGa1pyUXRIUUVsLTRCUGY0RkIxSWlJT0ZYbFlWc0JLRUZnWHBEcGw5bF9NbTZpSEJOQ2ZfckppM0NRODdYS1N1c3FZc1U3ZmRFNTVYSGRxLQ?oc=5","date":"2026-02-11","type":"deal","source":"BioWorld News","summary":"Tempest Therapeutics outlines plans for acquired CAR T assets - BioWorld News","headline":"Tempest Therapeutics outlines plans for acquired CAR T assets","sentiment":"neutral"},{"date":"2026-02-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMlJXMF9Wd1o4RGZxSkVJVHA5Z1VYNkFrR3NrWDNiOExrYTFsamI1a1VYXzQwUmpxcHBnYkxheWl1eWtpZ3RrYUtMYmh5WTFjRDctTlJqcEFjQ0p1NHZhZ0NwTlFkb2Z4RmxVa2tHYUpfVC10cHVYeVBnUVNpOTFfTkdHT1c4TzJvNWU1WUYwa3NwV1lvNmo1WHNFSUl3ZFYxQmp6MDViN0w?oc=5","date":"2025-11-19","type":"pipeline","source":"Fierce Biotech","summary":"Tempest turns to Factor for lifeline, trading majority stake for CAR-Ts and CEO - Fierce Biotech","headline":"Tempest turns to Factor for lifeline, trading majority stake for CAR-Ts and CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNZWNaTldGeEVZV0hMSU5qYXI1VEVJN0xReTAyNzRzdzZWOWtITjR3YmpsOG1rTlBsX0J5ZjNHM3FjX3gtSmlJTWJGYnlsUEN2dzhOXy1oN3N1THFHVS1vbi1tRVZncWo5dGVSZDZjbnJ1bnN6ZElvMUVSRGxtX1RiVFpjc0c0eWpfUVRWME55MDN5clJpRXdvMlFPM0NEanRSclZxalFzV0hFa25tcjZrUHJlTnFGSmJXRlJtRmp3?oc=5","date":"2025-11-19","type":"deal","source":"stocktitan.net","summary":"Tempest (Nasdaq: TPST) to buy CD19/BCMA Dual-CAR T assets, runway to mid 2027 - stocktitan.net","headline":"Tempest (Nasdaq: TPST) to buy CD19/BCMA Dual-CAR T assets, runway to mid 2027","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPam4tSmhvN2QxQmpuWXNES2l1TTRGd2xsYXAzNUJDZVFWZzhaU2U1QV84YWZ2RHNlSHpUX1JiYVJjNjNnVkZiRTBpNEpGUS1sSE9hZjkzcnFuVkt2ZUV1VVdiMF9kVTFGMXN1SFN1YmNodDVjNkl3a0lmS2FVQmQ3T1pIQzN2LTZtSzdkN0lYT2lvUlVvempqSGdXdWMwTzBEMW1VMTZMbjZ6ZEdMTXFhMlJfZWw0UzI5b2hkT0Y1Tl9lNWQwU1ZrMTk2cmZZcDYt?oc=5","date":"2025-08-13","type":"pipeline","source":"Business Wire","summary":"Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer - Business Wire","headline":"Vividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE0wWmFVcWplRWJpSHhNRUVydlhkYV9QRThYOUZNcU9lejJUVFlTRjlualBVOXprMGhWRWxDcHRIUFhQbWk2aXdvandhZDVmOTZjcXVUSUY5bUQycDJuckdvY21n?oc=5","date":"2025-04-22","type":"pipeline","source":"The Pharma Letter","summary":"Tempest Therapeutics - The Pharma Letter","headline":"Tempest Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOVm53cnI0dk1Qa3Jra2M1a2l1aDFfVWpkb3RNUE05T1VxNDJTZkJxWVdOcmIwUklDLUdkbzdnbVhtY2hObmdsMTdVZFlUU0hlb0thQXl2UzB6ejhOYmswcDF2R1VjVE1TU0FEVlU1Ujg4NUdlYzh1MXlWblRDUDNjbXVDWWhvVmxDS2xTTTB1QzJrTkNz?oc=5","date":"2025-04-21","type":"pipeline","source":"Fierce Biotech","summary":"Tempest lays off 80% of workforce to ride out cash crunch - Fierce Biotech","headline":"Tempest lays off 80% of workforce to ride out cash crunch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNMmtKX2VFT04wLWZlNS1LMExjZGhINUtSeDI4UVh0ODV4NnE0cG5LQTJheXlKamRvX0g2SnRyQXFWXzg1UnN2NExldGdfdE4xYzVaQS1jUEs5bl9qa1EyZHg2U3d2QjY3akRpYjk2QURZc1E1Mm9LdnZ5bFRsM19KbDd2OXd6dWdNNW5GS1dwOHlfbE9YSW5laHFGSQ?oc=5","date":"2025-04-10","type":"trial","source":"BioPharma Dive","summary":"Tempest seeks strategic alternatives as cash runs out for Phase 3 trial - BioPharma Dive","headline":"Tempest seeks strategic alternatives as cash runs out for Phase 3 trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":295000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":295000,"period":"2017-12-31"},{"value":653000,"period":"2016-12-31"},{"value":653000,"period":"2016-12-31"},{"value":277000,"period":"2015-12-31"},{"value":277000,"period":"2015-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":18337000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-41843000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":41488000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}